( Journal of Clinical Investigation ) This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Dec. 10, 2012, in the JCI: Brown fat transplants help mice lose weight; Researcher…
Imprime PGG in Combination with Monoclonal Antibody Therapy Achieves 64 … – MarketWatch (press release)
Imprime PGG in Combination with Monoclonal Antibody Therapy Achieves 64 …MarketWatch (press release)Research shows that early monoclonal antibody (mAb) therapy with alemtuzumab and rituximab is effective and could possibly delay first standard treatm…
Experts for awareness on organ donation – Jagran Post
Jagran PostExperts for awareness on organ donationJagran Post"If 20 per cent of families whose member had a brain death donate his or her organs, all requirements for organ transplantation in this country would be fulfilled," D.S. Rana, chair…
Dog receives landmark muscle transplant surgery
Bella, a border collie, faces a "ruff" recovery after a first-of-its-kind surgery. Bella seriously injured her leg falling off furniture three months ago. But thanks to landmark muscle transplant surgery performed at Angell Animal Medical Cen…
Dog receives landmark muscle transplant surgery – CNYcentral.com
Dog receives landmark muscle transplant surgeryCNYcentral.comBut thanks to landmark muscle transplant surgery performed at Angell Animal Medical Center in Boston, she can go for walks again. "The was actually pulled back to the side the dog tricep…
TG Therapeutics, Inc. Announces Poster Presentation Highlights for Ublituximab … – GlobeNewswire (press release)
TG Therapeutics, Inc. Announces Poster Presentation Highlights for Ublituximab …GlobeNewswire (press release)In vitro / in vivo results demonstrate superior efficacy with ublituximab compared to rituximab in primary central nervous system lymphomas, …
New Data Highlighting Long-Term Efficacy and Safety Outcomes of PNH Patients Treated with Soliris® Reported at ASH …
Alexion Pharmaceuticals, Inc. today announced the presentation of new data demonstrating the long-term benefits of Soliris® in patients with paroxysmal nocturnal hemoglobinuria , a debilitating, ultra-rare and life-threatening blood disorder character…
TG Therapeutics, Inc. Announces Poster Presentation Highlights for Ublituximab … – MarketWatch (press release)
TG Therapeutics, Inc. Announces Poster Presentation Highlights for Ublituximab …MarketWatch (press release)In vitro / in vivo results demonstrate superior efficacy with ublituximab compared to rituximab in primary central nervous system lymphomas, in…
Rituximab Benefits Some APS Non-Criteria Manifestations – Monthly Prescribing Reference
Rituximab Benefits Some APS Non-Criteria ManifestationsMonthly Prescribing Reference(HealthDay News) – Some patients with antiphospholipid syndrome with non-criteria manifestations may improve after treatment with rituximab, according to a study publ…
Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in Relapsed Hodgkin Lymphoma and Other CD30-Positive …
Seattle Genetics, Inc. today summarized ADCETRIS data in relapsed Hodgkin lymphoma and other CD30-positive malignancies from multiple presentations at the 54th American Society of Hematology Annual Meeting and Exposition being held December 8-11, 2012 …